CD4 and neoplasm: CD4+ Tregs are a highly immuno‐suppressive subset of CD4+ T cells, characterized by the expression of the master regulatory transcription factor FoxP3, (Fontenot et al., 2003) and promote tumour progression by suppressing effective antitumor immunity (Sakaguchi et al., 2010).